Zhang Ming-Qing, Li Chun-Sheng
Department of Emergency Medicine, Beijing Jishuitan Hospital, Beijing, 100035, China.
Department of Emergency Medicine, Critical Care Center, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, 100050, China.
Chin J Integr Med. 2023 Dec;29(12):1142-1146. doi: 10.1007/s11655-023-3631-2. Epub 2023 May 24.
Shock is the clinical manifestation of acute circulatory failure, which results in inadequate utilization of cellular oxygen. It is a common condition with high mortality rates in intensive care units. The intravenous administration of Shenfu Injection (SFI) may attenuate inflammation, regulate hemodynamics and oxygen metabolism; inhibit ischemia-reperfusion responses; and have adaptogenic and antiapoptotic effects. In this review, we have discussed the clinical applications and antishock pharmacological effects of SFI. Further in-depth and large-scale multicenter clinical studies are warranted to determine the therapeutic effects of SFI on shock.
休克是急性循环衰竭的临床表现,可导致细胞氧利用不足。它是重症监护病房中常见且死亡率高的病症。静脉注射参附注射液(SFI)可能减轻炎症、调节血流动力学和氧代谢;抑制缺血再灌注反应;并具有适应原样作用和抗凋亡作用。在本综述中,我们讨论了SFI的临床应用和抗休克药理作用。有必要进行进一步深入的大规模多中心临床研究,以确定SFI对休克的治疗效果。